Navigation Links
Study to Investigate AHCC and the Swine Flu Virus
Date:6/1/2009

Prior studies published in peer-reviewed journals have shown the benefits of AHCC against influenza, avian flu, west nile virus and MRSA.

BEAVERTON, Ore., June 1 /PRNewswire/ -- A study evaluating the effect of AHCC (Active Hexose Correlated Compound) on supporting the immune system in response to the swine flu virus will be conducted at the Southern China Agricultural University, one of the few research centers in China that have been approved to conduct studies on highly infectious diseases such as the swine flu. This controlled study will examine the effects of AHCC when supplemented to a group of mice infected with the virus.

Two years ago, following the avian flu outbreak, the same university conducted a study in mice on the effect of AHCC on the bird flu (H5N1) virus. The findings, published in the Japanese Journal of Complementary and Alternative Medicine (Vol. 4, (2007), No. 1 pp. 37-40), demonstrated that AHCC enhanced host resistance against bird flu. Other papers published in peer-reviewed journals include studies on AHCC and the common influenza (H1N1), the West Nile Virus and hospital-borne infections including MRSA.

"The animal study published by my group in the recent issue of Journal of Nutrition suggested that dietary supplementation with AHCC may be immunotherapeutic for the West-Nile Virus potentially susceptible populations." said Tian Wang, Assistant Professor at the Departments of Microbiology, Immunology and Pathology at the University of Texas Medical Branch at Galveston. "So in light of our findings and similar conclusions of Drexel University's study on influenza, I think that a study on AHCC and the swine flu is very timely and likely to yield useful information on the value of AHCC in combating this virus".

Published human clinical studies have shown that AHCC activates NK cells and DC Cells, which are the body's frontline defense against viruses and infections. A recent study at the Yale Medical School also showed that AHCC increases the production of cytokines which act as chemical messengers that activate the immune system when the body comes under attack.

"AHCC is the only natural compound that I know of which has been studied not only for influenza but also for several other important virus strains." said Fred Pescatore, MD, MPH of the Center for Integrative and Complementary Medicine. "The combination of the animal research on those specific strains and the significant clinical data on the efficacy of AHCC in humans makes this compound a very compelling target for further research specifically against the swine flu."

What is AHCC (Active Hexose Correlated Compound)?

AHCC is a natural compound derived from the hybridization of several subspecies of medicinal mushroom. AHCC is used by hundreds of healthcare facilities around the world and by hospitals as a part of a standard regimen for incoming patients to reduce the risk of hospital infections. AHCC is supported by more than 20 studies published in major peer-reviewed medical journals (key term "active hexose correlated compound" at www.PubMed.org).

To learn more about AHCC, please visit the AHCC Research Association Website at www.AHCCresearch.org.


'/>"/>
SOURCE AHCC Research Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations
2. New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography
3. Study shows gay couples want legal rights, regardless of marriage
4. Hopkins study: When adult patients have anxiety disorder, their children need help too
5. Study shows drug combination improves outcome for advanced non-small cell lung cancer
6. New Study Shows Probiotics Linked to Metabolism
7. New study indicates that parents influence on childrens eating habits is small
8. Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities
9. Music may improve feeding, reduce pain in premature babies: U of A study
10. Study Finds Multitude of Bacteria on Human Skin
11. Cancer Survivors Can Still Be Fit, Study Asserts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Florida (PRWEB) , ... May 26, 2016 , ... ... House® Project offering a new model of care for living and healing, celebrated ... core values: Meaningful Life in a Real Home provided by Empowered Staff. , “This ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: